Skip to main content

MERIT MEDICAL SYSTEMS INC

For the period ended Jan 28, 2025. Filed Jan 28, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Jan 28, 2025 · Filed Jan 28, 2025

Use the contents to explore the available documents and sections.

MMSI$87.23-2.7%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Current Report and the exhibit hereto contain forward-looking statements about Merit that involve substantial risks and uncertainties. Merit intends such statements, and all subsequent forward-looking statements attributable to Merit, to be expressly qualified in their entirety by these cautionary statements and covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and Section 27A of the Securities Act. In some cases, forward-looking statements can be identified by the use of terminology such as “anticipate,” “believe,” “continue,” “estimate,” “expect,” “forecast,” “intend,” “may,” “might,” “plan,” “potential,” “project,” “will,” “would,” “seek,” “should,” “could,” “can,” “predict,” “potential,” “continue,” “objective” or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. However, not all forward-looking statements contain such identifying words. All statements included in this Current Report and the exhibit hereto, other than statements of historical fact, are forward-looking statements for purposes of the Exchange Act and the Securities Act, including any projections of revenues or other financial items, statements regarding plans, objectives or development of existing or future products (including, without limitation, the Wrapsody CIE), statements concerning the prospective markets, reimbursement practices, anticipated regulatory approvals or commercial opportunities for existing or future products (including, without limitation, the Wrapsody CIE), statements regarding future economic conditions or performance, and statements of assumptions underlying any of the foregoing.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Merit’s actual results, levels of activity, performance or achievement to be materially different from those expressed or implied by these forward-looking statements, including those risks, uncertainties and other factors described in Merit’s Annual Report on Form 10-K for the year ended December 31, 2023 and Merit’s Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2024, June 30, 2024, and September 30, 2024 and subsequent filings with the SEC.

All forward-looking statements included in this Current Report and the exhibit hereto speak only as of the date made, are based on information available to Merit as of such date, and are subject to change. Merit assumes no obligation to update or revise any forward-looking statement. If Merit does update or correct one or more forward-looking statements, readers should not conclude that Merit will make additional updates or corrections. Merit’s actual results will likely differ, and may differ materially, from anticipated results. Readers should not unduly rely on any such forward-looking statements.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

​​​
EXHIBIT NUMBERDESCRIPTION
99.1​Conference Call Remarks.
104​The cover page from this Current Report on Form 8-K, formatted in Inline XBRL
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.